Holen Sie sich die Stockscreener-App
40.46
2.02%
-0.835
Schlusskurs vom Vortag:
$41.30
Offen:
$41.13
24-Stunden-Volumen:
887.50K
Relative Volume:
1.70
Marktkapitalisierung:
$2.04B
Einnahmen:
$226.84M
Nettoeinkommen (Verlust:
$3.55M
KGV:
578.00
EPS:
0.07
Netto-Cashflow:
$-12.02M
1W Leistung:
-1.12%
1M Leistung:
+3.88%
6M Leistung:
-31.12%
1J Leistung:
-15.18%
1-Tages-Spanne:
$39.16
$41.45
1-Wochen-Bereich:
$39.16
$42.92
52-Wochen-Spanne:
$37.39
$63.00
Vericel Corp Stock (VCEL) Company Profile
Firmenname
Vericel Corp
Sektor
Branche
Telefon
(734) 930-5555
Adresse
64 SIDNEY ST., CAMBRIDGE, MA
Vergleichen Sie VCEL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VCEL
Vericel Corp
|
40.46 | 2.12B | 226.84M | 3.55M | -12.02M | 0.07 |
|
ONC
Beone Medicines Ltd Adr
|
245.93 | 25.76B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
445.43 | 114.53B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.415 | 40.54M | 0 | 0 | 0 | 0.00 |
|
VRNA
Verona Pharma Plc Adr
|
84.10 | 6.44B | 0 | -153.72M | -103.81M | -2.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
490.81 | 65.13B | 14.09B | 4.50B | 2.96B | 39.28 |
Vericel Corp Stock (VCEL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-08-09 | Eingeleitet | Canaccord Genuity | Buy |
| 2024-06-20 | Eingeleitet | TD Cowen | Buy |
| 2024-01-25 | Hochstufung | Truist | Hold → Buy |
| 2023-08-08 | Hochstufung | BTIG Research | Neutral → Buy |
| 2022-11-10 | Herabstufung | BTIG Research | Buy → Neutral |
| 2022-11-09 | Herabstufung | Truist | Buy → Hold |
| 2022-10-14 | Fortgesetzt | Stephens | Overweight |
| 2021-01-11 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2020-12-18 | Eingeleitet | Stephens | Overweight |
| 2020-09-17 | Eingeleitet | Truist | Buy |
| 2019-10-09 | Eingeleitet | H.C. Wainwright | Buy |
| 2019-02-28 | Herabstufung | Needham | Buy → Hold |
| 2018-08-08 | Bestätigt | Needham | Buy |
| 2018-07-16 | Hochstufung | Ladenburg Thalmann | Neutral → Buy |
| 2018-04-04 | Eingeleitet | Leerink Partners | Outperform |
| 2018-03-06 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2018-03-06 | Bestätigt | Needham | Buy |
| 2018-03-05 | Bestätigt | BTIG Research | Buy |
| 2017-06-21 | Eingeleitet | BTIG Research | Buy |
| 2017-03-13 | Bestätigt | Needham | Buy |
| 2016-12-22 | Eingeleitet | Piper Jaffray | Overweight |
| 2016-11-09 | Bestätigt | Needham | Buy |
| 2016-04-05 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2016-03-11 | Hochstufung | Needham | Hold → Buy |
Alle ansehen
Vericel Corp Aktie (VCEL) Neueste Nachrichten
Bank of America Corp DE Sells 1,579 Shares of Vericel Co. (NASDAQ:VCEL) - Defense World
Vericel’s (VCEL) Overweight Rating Reiterated at Stephens - Defense World
What Analysts Are Saying About Vericel Stock - Benzinga
Vericel (VCEL) Maintains Overweight Rating by Stephens & Co. | V - GuruFocus
Vericel Co. (NASDAQ:VCEL) Shares Purchased by Deutsche Bank AG - Defense World
Vericel Co. (NASDAQ:VCEL) Stock Position Cut by BNP Paribas Financial Markets - Defense World
Truist maintains Buy on Vericel shares with $52 target By Investing.com - Investing.com India
Truist maintains Buy on Vericel shares with $52 target - Investing.com
VCEL to Be Featured in Upcoming Investor Meetings | VCEL Stock N - GuruFocus
Brokerages Set Vericel Co. (NASDAQ:VCEL) Price Target at $60.86 - Defense World
Vericel at BofA Securities Conference: Growth and Innovation in Healthcare By Investing.com - Investing.com India
Vericel at BofA Securities Conference: Growth and Innovation in Healthcare - Investing.com Australia
Transcript : Vericel Corporation Presents at BofA Securities 2025 Healthcare Conference, May-14-2025 09 - marketscreener.com
VCEL: Upcoming Meeting and Market Insights | VCEL Stock News - GuruFocus
First Trust Advisors LP Lowers Stock Holdings in Vericel Co. (NASDAQ:VCEL) - Defense World
Vericel Co. (NASDAQ:VCEL) Shares Sold by Tower Research Capital LLC TRC - Defense World
Vericel Corporation (NASDAQ:VCEL) Q1 2025 Earnings Call Transcript - Insider Monkey
Vericel (VCEL) Maintains Buy Rating Despite Target Price Adjustm - GuruFocus
Vericel (VCEL) Maintains Buy Rating Despite Target Price Adjustment | VCEL Stock News - GuruFocus
Vericel Corp (VCEL) Q1 2025 Earnings Call Highlights: Record Revenue and Strategic Growth ... - Yahoo Finance
Vericel Corp Ord earnings missed by $0.10, revenue fell short of estimates - Investing.com India
Decoding Vericel Corp (VCEL): A Strategic SWOT Insight - GuruFocus
Earnings call transcript: Vericel Corp Q1 2025 sees revenue growth, stock steady - Investing.com India
Vericel Q1 2025 slides: record revenue offset by widening losses, raises guidance - Investing.com South Africa
Vericel Corporation Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
Vericel (VCEL) Reports Slightly Lower Than Expected Q1 Revenue | VCEL Stock News - GuruFocus
Vericel's Q1 Loss Widens, Revenue Rises; 2025 Revenue Growth Outlook Reiterated - marketscreener.com
VCEL Updates Revenue and Profitability Outlook for 2023 | VCEL Stock News - GuruFocus
Vericel Corporation (VCEL) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance
Vericel Corp SEC 10-Q Report - TradingView
Vericel Corporation (VCEL): Among Stocks with Insanely High PE Ratios Insiders Are Selling - Insider Monkey
Vericel Corp Reports Q1 2025 Earnings: EPS of -$0.23 Misses Estimates, Revenue of $52.6M Below Expectations - GuruFocus
Vericel Corporation Q1 2025 Financial Results - TradingView
Earnings Flash (VCEL) VERICEL CORPORATION Reports Q1 Revenue $52.6M, vs. FactSet Est of $53.8M - marketscreener.com
Hsbc Holdings PLC Invests $405,000 in Vericel Co. (NASDAQ:VCEL) - The AM Reporter
Earnings To Watch: Vericel Corp (VCEL) Reports Q1 2025 Result - GuruFocus
Vericel to Present at the Bank of America Securities 2025 Healthcare Conference on Wednesday, May 14, 2025 - Stock Titan
Vericel’s 36% drop confirms InvestingPro’s January overvaluation warning By Investing.com - Investing.com
Vericel shareholders approve key incentive plans - Investing.com
Financial Health Report: Vericel Corp (VCEL)’s Ratios Tell a Tale - DWinneX
VCEL underperforms with a -0.26 decrease in share price - uspostnews.com
VCEL stock touches 52-week low at $37.42 amid market challenges - Investing.com
Vericel Corp. (VCEL) Faces Challenges as Burn Care Revenue Wanes and MACI Growth Remains Uncertain - MSN
Vericel to Report First-Quarter 2025 Financial Results on May 8, 2025 - Yahoo Finance
Vericel Co. (NASDAQ:VCEL) Shares Purchased by Bank of Montreal Can - Defense World
Closing Bell Recap: Vericel Corp (VCEL) Ends at 49.62, Reflecting a -6.11 Downturn - DWinneX
VCEL’s Market Quandary: Decoding the Ups and Downs of 2023 - investchronicle.com
Vericel Co. (NASDAQ:VCEL) Shares Acquired by Wells Fargo & Company MN - Defense World
Renaissance Technologies LLC Buys 9,200 Shares of Vericel Co. (NASDAQ:VCEL) - Defense World
Analyzing Vericel (NASDAQ:VCEL) and Sangamo Therapeutics (NASDAQ:SGMO) - Defense World
Finanzdaten der Vericel Corp-Aktie (VCEL)
Umsatz
Nettogewinn
Free Cashflow
ENV
6.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):